Key points are not available for this paper at this time.
You have accessJournal of UrologyHealth Services Research: Quality Improvement over 50% of these general payments were non-continuing medical education-related compensations. 38 urologists (0. 47% of all urologists receiving payments) accepted payments of all 3 categories, receiving a total of 29 million (20% of all payments made to urologists). Boston Scientific and Urovant Sciences contributed the biggest number of individual payments, while Merck contributed the largest total amount (32. 6M) (Table 2). CONCLUSIONS: Disproportionate amount of industry payments were made with 0. 1% of urologists receiving 26% of the total payments in 2022. Research payments are the largest industry payment category to urologists. Further studies are warranted to better understand the nature of this industry-urologist relationship and its impact on physician decision making. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc. FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e564 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc. Metrics Author Information Joseph Cheaib More articles by this author Zhuo Su More articles by this author Zeyad Hammadeh More articles by this author Bruce J. Trock More articles by this author Misop Han More articles by this author Expand All Advertisement PDF downloadLoading. . .
Cheaib et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: